JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that ZECUITY®, the first and only patch system designed to provide relief from migraine, is now available by prescription through specialty pharmacies.

Today, the U.S. Food and Drug Administration allowed marketing of the first device as a preventative treatment for migraine headaches.

Taylor Williams, 17, of Wixom, Mich., has suffered from severe headaches for more than two years. The headaches, which caused Taylor to seek medical treatment including emergency care on a number of occasions, were continuous and the medications prescribed were not working.